Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Whiting

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Biochemical Pharmacology|March 24, 1993
The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibitionE M Grieve, G M Hawksworth, J G Simpson, et al.
British Journal of Biomedical Science|December 6, 2008
The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitusP H Whiting, A Kalansooriya, I Holbrook, et al.
Lancet (London, England)|January 19, 1985
Cyclosporin and skin diseaseR D Aldridge, J G Simpson, P H Whiting, et al.
British Medical Journal (Clinical Research Ed.)|January 29, 1983
Popular marathons: forecasting casualtiesP H Whiting, R J Maughan, J D Miller, et al.
Biochemical Pharmacology|November 15, 1990
Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicityE M Grieve, G M Hawksworth, J G Simpson, et al.
Agents and Actions|June 1, 1987
Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activityF T McAuley, J G Simpson, A W Thomson, et al.
British Journal of Experimental Pathology|August 1, 1989
Renal structure and function in streptozotocin-diabetic rats treated with cyclosporin AK J Thomson, N J Saunders, J G Simpson, et al.
Eye (London, England)|January 1, 1989
Low dose cyclosporin A therapy in chronic posterior uveitisH M Towler, A M Cliffe, P H Whiting, et al.
Biochemical Pharmacology|December 3, 1993
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the ratK E Adams, P A Brown, S D Heys, et al.
British Journal of Experimental Pathology|August 1, 1983
Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeksP H Whiting, J G Simpson, R J Davidson, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Biochemical Pharmacology|March 24, 1993
The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibitionE M Grieve, G M Hawksworth, J G Simpson, et al.
British Journal of Biomedical Science|December 6, 2008
The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitusP H Whiting, A Kalansooriya, I Holbrook, et al.
Lancet (London, England)|January 19, 1985
Cyclosporin and skin diseaseR D Aldridge, J G Simpson, P H Whiting, et al.
British Medical Journal (Clinical Research Ed.)|January 29, 1983
Popular marathons: forecasting casualtiesP H Whiting, R J Maughan, J D Miller, et al.
Biochemical Pharmacology|November 15, 1990
Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicityE M Grieve, G M Hawksworth, J G Simpson, et al.
Agents and Actions|June 1, 1987
Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activityF T McAuley, J G Simpson, A W Thomson, et al.
British Journal of Experimental Pathology|August 1, 1989
Renal structure and function in streptozotocin-diabetic rats treated with cyclosporin AK J Thomson, N J Saunders, J G Simpson, et al.
Eye (London, England)|January 1, 1989
Low dose cyclosporin A therapy in chronic posterior uveitisH M Towler, A M Cliffe, P H Whiting, et al.
Biochemical Pharmacology|December 3, 1993
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the ratK E Adams, P A Brown, S D Heys, et al.
British Journal of Experimental Pathology|August 1, 1983
Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeksP H Whiting, J G Simpson, R J Davidson, et al.
Pageof 15